A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy
Cancer Research and Treatment. 2021;53(1):233-242 
Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy
Annals of Surgical Oncology. 2015;23(1):163-170
Long-term bladder function in patients with locally advanced cervical carcinoma treated with neoadjuvant chemotherapy and type 3-4 radical hysterectomy
Cancer. 2004;100(10):2110-2117
Neoadjuvant Intraarterial Chemotherapy Followed by Radical Hysterectomy and/or Radiotherapy for Locally Advanced Cervical Cancer
Gynecologic Oncology. 1998;69(2):130-136
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass
OncoTargets and Therapy. 2016;Volume 9:5651-5657
Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study
Cancer/Radiothérapie. 2002;6(5):320-321
Clusterin Expression Inversely Correlates with Chemosensitivity and Predicts Poor Survival in Patients with Locally Advanced Cervical Cancer Treated with Cisplatin-Based Neoadjuvant Chemotherapy and Radical Hysterectomy
Pathology & Oncology Research. 2010;16(3):345-352
Development and Validation of a Preoperative Nomogram for Predicting Survival of Patients with Locally Advanced Prostate Cancer after Radical Prostatectomy
. 2019;
Development and Validation of a Preoperative Nomogram for Predicting Survival of Patients with Locally Advanced Prostate Cancer after Radical Prostatectomy
. 2020;
Long-term Outcomes and Safety of Radical Transmediastinal Esophagectomy with Preoperative Docetaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Thoracic Esophagus
. 2020;